Circulating P3NP and Cardiovascular Events in Hemodialysis Patients
NCT03391128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 244
Last updated 2018-01-08
Summary
This study evaluates whether circulating levels of aminoterminal propeptide of type III procollagen (PIIINP) can predict the cardiovascular events in hemodialysis patients.
Conditions
- Cardiovascular Events
- Cardiac Fibrosis
Sponsors & Collaborators
-
Toujinkai Hospital
lead OTHER
Principal Investigators
-
Masato Nishimura, MD · Tojinkai Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-01
- Primary Completion
- 2005-01-31
- Completion
- 2005-01-31
Countries
- Japan
Study Locations
More Related Trials
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
NCT00513825 ·Status: COMPLETED ·Phase: PHASE2
-
Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.
NCT01229072 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
NCT01144091 ·Status: WITHDRAWN ·Phase: NA
-
PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization
NCT02980003 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
NCT00700375 ·Status: COMPLETED ·Phase: PHASE4
-
Hemofiltration for Contrast-Induced Nephropathy
NCT00158080 ·Status: UNKNOWN ·Phase: NA
-
Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
NCT01103336 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP
NCT00584350 ·Status: UNKNOWN ·Phase: PHASE4
-
Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)
NCT00749827 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Remote Ischemic Preconditioning on the Incidence of Contrast Induced Nephropathy in Patients Undergoing EVAR
NCT05350683 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes
NCT00948116 ·Status: RECRUITING
-
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
NCT00639912 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
NCT00606827 ·Status: COMPLETED ·Phase: PHASE4
-
Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
NCT06334692 ·Status: RECRUITING
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
NCT00390585 ·Status: COMPLETED ·Phase: PHASE4
-
Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy
NCT00693329 ·Status: COMPLETED
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906 ·Status: TERMINATED ·Phase: PHASE2
-
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
NCT06139952 ·Status: COMPLETED ·Phase: PHASE4
-
Lithium in Acute Kidney Injury
NCT03056248 ·Status: UNKNOWN ·Phase: PHASE4